Abstract:Hepatocellular carcinoma (HCC), which is a type of malignant tumor, is the fifth most common cancer in men and ninth in women worldwide. The aim of the present study was to investigate the antitumor effect of diosmetin (DIOS) in hepatocellular carcinoma HepG2 cells. The proliferation, apoptosis and autophagy rates of HepG2 cells were measured following treatment with DIOS. The effects of DIOS treatment on HepG2 cell proliferation and apoptosis rates were analyzed using MTT assays and Annexin V staining, respectively. The effect of DIOS treatment on autophagy levels was assessed using transmission electron microscopy, green fluorescent protein (GFP)-microtubule-associated protein 1 light chain (LC3) transfection and LysoTracker Red staining. Furthermore, bafilomycin A1 (BA1), an autophagy inhibitor, was used to assess the association between DIOS and cell autophagy, proliferation and apoptosis. In addition, the expression of autophagy-related proteins [mammalian target of rapamycin (mTOR), phosphatidylinositol 3-kinase, P70S6K, phosphoinositide-dependent kinase-1, extracellular signal-regulated kinase, 5'-AMP-activated protein kinase and Akt] and apoptosis-related proteins [B-cell lymphoma (Bcl)-2-associated X protein, Bak, p53, Bcl-2 and caspase-3] were analyzed by western blotting. The results revealed that DIOS significantly inhibited proliferation (P<0.01) and induced apoptosis (P<0.001) in HepG2 cells. It was also demonstrated that DIOS triggered autophagy by regulating the mTOR pathway in HepG2 cells. Notably, following treatment of HepG2 cells with the autophagy inhibitor, BA1, the expression of apoptosis-related proteins, including Bax, Bak and p53, were significantly decreased (P<0.05), and cell viability was recovered to a certain extent. In conclusion, DIOS inhibits cell proliferation and induces apoptosis in HepG2 cells via regulation of the mTOR pathway. Thus, the results of the current study indicate that DIOS may present a potential therapeutic agent for HCC treatment.

Diosgenyl Saponin Inducing Endoplasmic Reticulum Stress and Mitochondria-Mediated Apoptotic Pathways in Liver Cancer Cells.

Diosgenin Derivatives As Potential Antitumor Agents: Synthesis, Cytotoxicity, and Mechanism of Action

Design and Synthesis of Diosgenin Derivatives As Apoptosis Inducers Through Mitochondria-Related Pathways.

Novel Diosgenin Derivatives Containing 1,3,4-Oxadiazole/thiadiazole Moieties As Potential Antitumor Agents: Design, Synthesis and Cytotoxic Evaluation

Anticancer Activity of Diosgenin and Its Molecular Mechanism

Diosgenin-3-O-α-l-Rhamnopyranosyl-(1→4)-β-d-glucopyranoside Obtained As a New Anticancer Agent Fromdioscorea Futschauensisinduces Apoptosis on Human Colon Carcinoma HCT-15 Cellsviamitochondria-Controlled Apoptotic Pathway

Apoptotic Effects of Diosgeninlactoside on Oral Squamous Carcinoma Cells in Vitro and in Vivo

Diosgenin Induces ROS-dependent Autophagy and Cytotoxicity Via Mtor Signaling Pathway in Chronic Myeloid Leukemia Cells

Diosmetin induces apoptosis and protective autophagy in human gastric cancer HGC-27 cells via the PI3K/Akt/FoxO1 and MAPK/JNK pathways

Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.

Diosgenin Induces Cell Cycle Arrest and Apoptosis in Human Leukemia K562 Cells with the Disruption of Ca2+ Homeostasis

Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review

The mitotic-arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines.

Diosgenin Suppresses Cholangiocarcinoma Cells Via Inducing Cell Cycle Arrest and Mitochondria-Mediated Apoptosis.

Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.

Anti-Proliferation and Apoptosis Induced by A Novel Intestinal Metabolite of Ginseng Saponin in Human Hepatocellular Carcinoma Cells

Diosmetin Induces Apoptosis by Downregulating AKT Phosphorylation Via P53 Activation in Human Renal Carcinoma ACHN Cells

Novel Derivatives of Diosgenin: Design, Synthesis and Anti-Tumor Activity

Diosgenin exerts anti-tumor effects through inactivation of cAMP/PKA/CREB signaling pathway in colorectal cancer

Dioscin Induces Gallbladder Cancer Apoptosis By Inhibiting Ros-Mediated Pi3k/Akt Signalling

Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells